HealthTree Logo
search more_vert
person Sign In / Create Account
Nanotechnology in Multiple Myeloma with Dr. Samuel Achilefu, Dr. Ravi Vij and Dr. Monica Shokeen, Washington University
Nanotechnology in Multiple Myeloma with Dr. Samuel Achilefu, Dr. Ravi Vij and Dr. Monica Shokeen, Washington University image
HealthTree Podcast for Multiple Myeloma
event May 06, 2016 / 11:00AM MDT

Event Description

Dr. Samuel Achilefu PhD Dr. Ravi Vij, MD Dr. Monica Shokeen, PhD, MBA Washigton University Interview Date: May 6, 2016

Nanotechnology is the study of very small things, down to the atom and molecule level. Based on the award-winning expertise of Dr. Samuel Achilefu and other experts, the Center for Multiple Myeloma Nanotechnology has now opened at Washington University in St. Louis and is considered a Center of Cancer Nanotechnology Excellence (CCNE).This group is one of six centers to receive a prestigious NIH grant to study nanotechnology in cancer and is the only center to study it in multiple myeloma. In this show, the doctors share that nanotechnology can be used to deliver existing or new drugs in a more targeted and more concentrated way, that it can also be paired with an imaging contrast agent to "light up" the cancer cells and target exactly where the treatment should go, and that it can kick out hiding myeloma cells into the blood so that it can be found and killed. This is a fascinating show that explores an exciting and completely new potential treatment for multiple myeloma. nanotherapy

Schedule & Agenda

Dr. Samuel Achilefu, Dr. Ravi Vij, Dr. Monica Shokeen & Jenny Ahlstrom

Speakers & Moderators

The panelist Ravi Vij, MD, MBA
Ravi Vij, MD, MBA

Ravi Vij, MD, MBA, is Professor of Medicine at the Washington University School of Medicine in the Division of Medical Oncology, Section of Bone Marrow Transplantation and Leukemia. Dr. Vij’s primary academic interests include the treatment of hematologic malignancies and hematopoietic stem cell transplantation. He has research interests in multiple myeloma and AML/myelodysplastic syndromes. Dr. Vij serves on numerous committees including the International Myeloma Working Group (IWMG), the Core Transplant Myeloma and Leukemia Committees of the CALGB, the Steering Committee of the Multiple Myeloma Research Consortium, and the Myeloma Committee of the BMT Clinical Trials Network (CTN). His honors include the Multiple Myeloma Research Foundation Innovator Award (2013) and the Multiple Myeloma Research Consortium Center of Excellence Award (2011). He has authored more than 130 publications in journals such as Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, and Biology of Blood and Marrow Transplantation. He has authored the book Contemporary Management of Multiple Myeloma and several chapters in books, including Multiple Myeloma and Plasma Cell Dyscrasias in the Washington Manual of Oncology. He has served as a review for journals including Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Experimental Hematology and Haematologica.

Read Bio
The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us




Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube